Merck News - MRK

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -2.58 -2.91% 85.98 88.825 85.58 88.79 88.56 19:59:37
more quote information »

Recent News

Date Time Source Heading
1/23/202008:21DJNMerck Gets Canada OK for Keytruda/Inlyta Combo in Renal Cell..
1/23/202007:31PRNCAHealth Canada Approves KEYTRUDA® (pembrolizumab) as..
1/22/202006:30GLOBEBriaCell Invited to Present at Mount Sinai’s Frontiers in..
1/21/202007:58DJNMyriad Submits sPMA for BRACAnalysis CDx Test
1/21/202007:43DJNAstraZeneca, Merck Get FDA Priority Review for Lynparza in..
1/21/202006:55BWFDA Accepts Regulatory Submission of Supplemental New Drug..
1/18/202009:00PRNUSSignificant Study on Veterinary Wellbeing Reveals Importance..
1/16/202008:34BWMerck Completes Acquisition of ArQule
1/15/202017:16EDGARStatement of Changes in Beneficial Ownership (4)
1/13/202007:43DJNAstraZeneca, Merck Get FDA Priority Review for Lynparza in..
1/13/202006:55BW FDA Accepts Regulatory Submission of Supplemental New Drug..
1/13/202006:30GLOBEBriaCell Provides Update on Remarkable Responder
1/10/202018:33DJNBristol-Myers Squibb, Macy's, Grubhub: Stocks That Defined..
1/09/202006:30GLOBEBriaCell Outlines New High Responding Patient Group..
1/08/202016:31BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients..
1/06/202017:08DJNMerck's Keytruda Study Shows Improvement for Patients Who..
1/06/202016:05BWMerck’s KEYTRUDA® (pembrolizumab) in Combination with..
1/06/202011:07PRNUSMoore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR,..
1/06/202006:30BWMerck Establishes Strategic Oncology Collaboration with..
1/03/202017:12EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202017:06EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202016:57EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202016:52EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202016:48EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202006:45BWMerck to Hold Fourth-Quarter and Full-Year 2019 Sales and..
1/02/202016:48GLOBEBriaCell Completes Share Consolidation
1/02/202006:45BWMerck to Present at the 38th Annual J.P. Morgan Healthcare..
12/30/201907:49DJNAstraZeneca, Merck Get FDA OK for Lynparza in Pancreatic..
12/30/201906:55BWLYNPARZA® (olaparib) Approved by FDA as First-Line..
12/24/201906:30GLOBEBriaCell Therapeutics Corp. Announces Share Consolidation
12/20/201912:21DJNMerck Shares Up; FDA Approves Ebola Zaire Vaccine Ervebo
12/20/201910:09GLOBENewLink Genetics Announces FDA Approval of Ebola Vaccine..
12/20/201908:03DJNMerck Says FDA Approves Ebola Zaire Vaccine Ervebo
12/20/201907:15BWMerck Announces FDA Approval for ERVEBO® (Ebola Zaire..
12/20/201906:45BWMerck’s KEYTRUDA® (pembrolizumab) Approved in Japan for..
12/17/201917:15BWFDA Oncologic Drugs Advisory Committee (ODAC) Recommends..
12/17/201917:00BWMerck Animal Health Completes Acquisition of Vaki to Further..
12/17/201915:05DJNAstraZeneca, Merck Say FDA Panel Recommends Lynparza in..
12/17/201914:09BWLYNPARZA® (olaparib) Recommended by FDA Advisory Committee..
12/17/201906:45BWMerck Begins Tender Offer to Acquire ArQule
12/17/201906:30GLOBEBriaCell to Present at Biotech Showcase™ 2020 in San..
12/16/201911:18EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
12/13/201906:30GLOBEBriaCell Announces Clinical Data as Presented at the 2019..
12/12/201915:49PRNUSSHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.
12/12/201914:06DJNAmneal Shares Up Nearly 50% on FDA Nod for NuvaRing Generic
12/12/201908:04DJNAmneal Gets FDA OK for First Generic of Merck's NuvaRing
12/12/201906:45BWData from Exploratory Analysis Show Merck’s KEYTRUDA®..
12/10/201903:02DJNMerck, Sanofi Push To Add Cancer Drugs -- WSJ
12/09/201919:16DJNBig Drugmakers Push Deeper Into Cancer Treatment -- 4th..
12/09/201916:37DJNBig Drugmakers Push Deeper Into Cancer Treatment -- 3rd..
See more news about this stock »
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200125 15:08:27